Amantadine (Symmetrel) as a safe to use - discussion
Amantadine (trade name Symmetrel, by Endo Pharmaceuticals) is a drug that has U.S. Food and Drug Administration approval for use both as an antiviral and an antiparkinsonian drug.
According to the U.S. Centers for Disease Control and Prevention, 100% of seasonal H3N2 and 2009 pandemic flu samples tested have shown resistance to adamantanes, and amantadine is no longer recommended for treatment of influenza in the United States. Additionally, its effectiveness as an antiparkinsonian drug is undetermined, with a 2003 Cochrane Review concluding that there was insufficient evidence in support or against its efficacy and safety. More: en.wikipedia.org.
0 opinions, 0 replies
Add your opinion:
Challenge someone to answer this topic:
Invite an OpiWiki user:
OR
Invite your friend via email:
@
click for template
OR
Share it:
Share this discussion via OpiWiki smartlink:
OR